The National Institutes of HealthTrusted Source project that doctors will diagnose at least 2 million new cancer cases and that 600,000 people will die from cancer in 2025 in the United States.
Despite improving cancer death ratesTrusted Source, this prediction highlights the need to continue developing more effective treatments.
Researchers from Rockefeller University made headway in this area with the completion of their human phase 1 study. They tested a new CD40 antibody drug, 2141-V11, designed to shrink tumors and reduce side effects.